Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Monday, February 24, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
admin
-
February 3, 2025
Latest Pharma-News
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
admin
-
February 3, 2025
Latest Pharma-News
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
admin
-
January 24, 2025
Latest Pharma-News
Bayer and Pula Foundation partner up to insure 10 million smallholder farmers in Sub-Saharan Africa and South Asia
admin
-
January 24, 2025
Latest Pharma-News
Phase II DESTINY-Gastric01 trial of Enhertu (trastuzumab deruxtecan) versus chemotherapy met primary endpoint
admin
-
January 29, 2020
0
Latest Pharma-News
AstraZeneca’s Brilinta met primary endpoint in Phase III THALES trial in stroke
admin
-
January 29, 2020
0
Latest Pharma-News
FDA accepts for priority review Sanofi’s Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis
admin
-
January 28, 2020
0
Latest Pharma-News
AstraZeneca divests rights to Inderal, Tenormin, Tenoretic, Zestril and Zestoretic to Atnahs Pharma (Atnahs) to established hypertension medicines
admin
-
January 28, 2020
0
Latest Pharma-News
Medtronic Launches Efficio™ Software to facilitate Clinicians Efficiently Manage Targeted Drug Delivery Therapy with SynchroMed™ II
admin
-
January 27, 2020
1
Latest Pharma-News
FDA approves Tazverik (tazemetostat) for the treatment of adults and pediatric patients with metastatic or locally advanced epithelioid sarcoma
admin
-
January 27, 2020
0
Latest Pharma-News
Celularity Announces FDA Clearance of IND for CYNK-001, an Allogeneic, Off-the-Shelf Cryopreserved NK Cell Therapy for glioblastoma multiforme (GBM)
admin
-
January 24, 2020
0
Latest Pharma-News
FDA Approves Medtronic Micra™ AV, the World’s Smallest Pacemaker with atrioventricular (AV) synchrony for the treatment of patients with AV block
admin
-
January 24, 2020
0
Latest Pharma-News
Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rx for the treatment of hypertriglyceridemia
admin
-
January 24, 2020
0
Latest Pharma-News
European Commission approves Darzalex® in combination with bortezomib, thalidomide and dexamethasone for multiple myeloma
admin
-
January 23, 2020
0
Latest Pharma-News
Jazz Pharmaceuticals reported that EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
admin
-
January 23, 2020
0
Latest Pharma-News
AstraZeneca’s ‘Desire Zero Carbon’ system to take out outflows by 2025 and be carbon negative over the whole worth chain by 2030
admin
-
January 23, 2020
0
1
...
131
132
133
...
145
Page 132 of 145
- Advertisment -
Most Read
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
February 10, 2025
Pfizer to Showcase Advancements Across Genitourinary Cancers at ASCO GU Cancers Symposium
February 3, 2025
FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain
February 3, 2025
Johnson & Johnson investigational therapy was recently granted U.S. FDA Priority Review for the treatment of gMG
January 24, 2025